| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |